Your June Newsletter is here!

This event is supported by a range of sponsors, including pharmaceutical companies.

A full list of sponsors can be found here.

Dear Colleague,

Welcome to your June Pharmacy Show newsletter!

It has been a significant month for community pharmacy, with the publication of the 2026/27 Community Pharmacy Contractual Framework confirming a 10.3% funding uplift and a national independent prescribing offer from autumn 2026. While questions remain around long-term sustainability, the contract marks another important step in pharmacy’s expanding clinical role.

Meanwhile, preparations for the Pharmacy Show 2026 are gaining speed. Registration is now open, and with the conference programme almost complete, we are looking forward to unveiling a line-up that reflects the sector’s most pressing priorities, challenges and opportunities.

REGISTER FOR YOUR FREE PASS* NOW

We hope you enjoy this month’s updates and insights,

Kind Regards,

Molly Benson

Senior Content Producer

The Pharmacy Show

Kind Regards,

Molly Benson

Content Producer

The Pharmacy Show

Pharmacy Show & Current News

Explore our latest articles by clicking on the titles below

*Free to attend for UK-registered

healthcare professionals

Registration for the Pharmacy Show 2026 is now LIVE!

We’re expecting this year’s show to be bigger and more connected than ever, with an expanded show floor and a new Networking Hour to spark meaningful conversations. Join 9,600+ pharmacy professionals for numerous business and networking opportunities.

REGISTER TODAY*

The 2026/27 Community Pharmacy Contractual Framework: what it means for community pharmacy

After months of anticipation, the Community Pharmacy Contractual Framework (CPCF) for 2026/27 has now been agreed. While negotiations around pharmacy funding rarely exist in isolation, this year's settlement has attracted particular attention due to the wider...

An overview of the UK community pharmacy landscape 2026

This is an essential 2026 snapshot of community pharmacy in England, combining latest data, market trends and ownership shifts with analysis of funding, the contractual framework and NHS change, highlighting where the sector is heading and the opportunities.